Molecular Aspects of Pruritus Pathogenesis in Psoriasis.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
16 Jan 2021
Historique:
received: 27 12 2020
revised: 11 01 2021
accepted: 13 01 2021
entrez: 20 1 2021
pubmed: 21 1 2021
medline: 10 4 2021
Statut: epublish

Résumé

Psoriasis is a chronic, systemic inflammatory disease with a genetic background that involves almost 3% of the general population worldwide. Approximately, 70-90% of patients with psoriasis suffer from pruritus, an unpleasant sensation that provokes a desire to scratch. Despite the enormous progress in understanding the mechanisms that cause psoriasis, the pathogenesis of psoriasis-related pruritus still remains unclear. In order to improve patients' quality of life, development of more effective and safer antipruritic therapies is necessary. In turn to make it possible, better understanding of complexed and multifactorial pathogenesis of this symptom is needed. In this article we have systematized the current knowledge about pruritus origin in psoriasis.

Identifiants

pubmed: 33467067
pii: ijms22020858
doi: 10.3390/ijms22020858
pmc: PMC7830783
pii:
doi:

Substances chimiques

Cytokines 0
Lipocalin-2 0
Neuropeptides 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Int J Mol Sci. 2020 Nov 09;21(21):
pubmed: 33182442
J Immunol Res. 2019 Jan 21;2019:8171373
pubmed: 30805373
FASEB J. 2019 Feb;33(2):1578-1594
pubmed: 30204499
Br J Dermatol. 2003 Oct;149(4):718-30
pubmed: 14616362
J Am Acad Dermatol. 2020 Jun;82(6):1314-1320
pubmed: 32007513
J Am Acad Dermatol. 2018 May;78(5):882-891.e10
pubmed: 29462657
Handb Exp Pharmacol. 2015;226:315-35
pubmed: 25861787
Prostate. 2015 Jun 15;75(9):957-68
pubmed: 25728945
J Neurosci. 2013 May 29;33(22):9283-94
pubmed: 23719797
J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1316-1324
pubmed: 31736536
J Invest Dermatol. 2018 Jun;138(6):1311-1317
pubmed: 29317264
Arch Dermatol Res. 2008 Oct;300(9):461-78
pubmed: 18719932
Skin Pharmacol Physiol. 2010;23(3):133-8
pubmed: 20051714
Br J Dermatol. 2002 May;146(5):792-800
pubmed: 12000375
J Clin Invest. 2008 Apr;118(4):1468-78
pubmed: 18317594
Cutis. 2000 Nov;66(5):357-62
pubmed: 11107521
J Invest Dermatol. 2016 Jul;136(7):1418-1428
pubmed: 26979478
J Dermatol Sci. 2016 Aug;83(2):148-51
pubmed: 27156794
Br J Dermatol. 2007 Jun;156(6):1272-7
pubmed: 17535226
Exp Dermatol. 1998 Apr-Jun;7(2-3):81-96
pubmed: 9583747
Postepy Dermatol Alergol. 2017 Oct;34(5):457-463
pubmed: 29507561
Cell Rep. 2019 Jul 16;28(3):625-639.e6
pubmed: 31315043
Exp Dermatol. 2020 Apr;29(4):414-426
pubmed: 31954075
Acta Derm Venereol. 2020 Dec 9;100(19):adv00342
pubmed: 33104231
Br J Dermatol. 2000 Nov;143(5):969-73
pubmed: 11069504
Br J Dermatol. 2017 Oct;177(4):1052-1059
pubmed: 28314054
Acta Derm Venereol. 2007;87(4):299-304
pubmed: 17598031
J Dermatol Sci. 2009 Jan;53(1):48-54
pubmed: 18922683
Curr Neuropharmacol. 2018;16(10):1455-1465
pubmed: 29651949
Arch Dermatol Res. 2007 May;299(2):85-91
pubmed: 17370082
J Allergy Clin Immunol. 2006 Feb;117(2):418-25
pubmed: 16461143
Br J Dermatol. 2011 May;164(5):1023-9
pubmed: 21299544
Exp Dermatol. 2009 May;18(5):424-30
pubmed: 19382313
Blood. 1994 Feb 1;83(3):799-807
pubmed: 8298140
J Eur Acad Dermatol Venereol. 2007 Jan;21(1):72-8
pubmed: 17207171
Eur J Pain. 2016 Jan;20(1):41-6
pubmed: 26415584
Dermatol Ther (Heidelb). 2019 Sep;9(3):391-405
pubmed: 31190215
Postepy Dermatol Alergol. 2020 Apr;37(2):135-153
pubmed: 32489346
Genes Dev. 2000 Dec 1;14(23):2919-37
pubmed: 11114882
Am J Pathol. 2012 Jan;180(1):177-85
pubmed: 22063299
Acta Derm Venereol. 2017 Aug 31;97(8):928-933
pubmed: 28512665
Chronobiol Int. 2019 Dec;36(12):1733-1740
pubmed: 31645138
Br J Dermatol. 2011 Aug;165(2):277-84
pubmed: 21457210
J Eur Acad Dermatol Venereol. 2008 Jul;22(7):822-6
pubmed: 18422545
J Am Soc Nephrol. 2005 Dec;16(12):3742-7
pubmed: 16251241
Dermatol Ther. 2020 Jan;33(1):e13179
pubmed: 31769907
Clin Cosmet Investig Dermatol. 2020 Jun 19;13:419-424
pubmed: 32606880
J Dermatolog Treat. 2020 Oct 28;:1-4
pubmed: 33084462
J Invest Dermatol. 2011 Aug;131(8):1668-76
pubmed: 21614010
Clin Cosmet Investig Dermatol. 2009 Feb 19;2:9-13
pubmed: 21436964
Arch Dermatol Res. 1985;277(5):352-8
pubmed: 4026377
Arch Dermatol Res. 2013 Apr;305(3):191-5
pubmed: 23108364
An Bras Dermatol. 2018 Jun;93(3):368-372
pubmed: 29924253
Acta Derm Venereol. 1998 May;78(3):190-3
pubmed: 9602224
Acta Derm Venereol. 2017 May 8;97(5):564-570
pubmed: 27958613

Auteurs

Kamila Jaworecka (K)

Department of Dermatology, Institute of Medical Sciences, Medical College of Rzeszow University, PL-35-055 Rzeszow, Poland.

Joanna Muda-Urban (J)

Department of Dermatology, Institute of Medical Sciences, Medical College of Rzeszow University, PL-35-055 Rzeszow, Poland.

Marian Rzepko (M)

Institute of Physical Culture Sciences, Medical College of Rzeszow University, PL-35-055 Rzeszow, Poland.

Adam Reich (A)

Department of Dermatology, Institute of Medical Sciences, Medical College of Rzeszow University, PL-35-055 Rzeszow, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH